Return
Company Page
Mirae
Founders
Mirae is an AI-driven continuous care platform for autoimmune disease and other complex chronic conditions, initially focused on inflammatory bowel disease (IBD). Built on research from the University of Oxford's Computational Health Informatics Lab, Mirae uses conversational AI to capture patient experiences between clinical visits and convert them into structured, longitudinal health records. These insights are combined with clinical data and peer-reviewed evidence to give specialists a richer, more dynamic view of disease progression, enabling earlier intervention and more informed treatment decisions. The platform is actively deployed with a leading U.S. health system.
Company Founded in
Healthtech & Biotech